Pulmonary embolism differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 30: Line 30:
* [[Herpes zoster]]
* [[Herpes zoster]]
* [[Hyperventilation]]
* [[Hyperventilation]]
* [[Mediastinitis]]
* [[Mitral stenosis]]
* [[Mitral stenosis]]
* [[Musculoskeletal pain]]
* [[Musculoskeletal pain]]
Line 45: Line 46:
* [[Salicylate intoxication]]
* [[Salicylate intoxication]]
* [[Septic shock]]
* [[Septic shock]]
* [[Silicone]] pulmonary embolism<ref name="pmid19346851">{{cite journal| author=Restrepo CS, Artunduaga M, Carrillo JA, Rivera AL, Ojeda P, Martinez-Jimenez S et al.| title=Silicone pulmonary embolism: report of 10 cases and review of the literature. | journal=J Comput Assist Tomogr | year= 2009 | volume= 33 | issue= 2 | pages= 233-7 | pmid=19346851 | doi=10.1097/RCT.0b013e31817ecb4e | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19346851  }} </ref>
* [[Sudden cardiac death]]
* [[Sudden cardiac death]]
* [[Superior vena cava syndrome]]
* [[Superior vena cava syndrome]]
* [[Syncope]]
* [[Syncope]]
* [[Toxic shock syndrome]]
* [[Toxic shock syndrome]]
* [[Trauma]] to the chest
* [[Viral pneumonia]]
* [[Viral pneumonia]]



Revision as of 22:30, 7 July 2014

Pulmonary Embolism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary Embolism from other Diseases

Epidemiology and Demographics

Risk Factors

Triggers

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

Assessment of Clinical Probability and Risk Scores

Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores

History and Symptoms

Physical Examination

Laboratory Findings

Arterial Blood Gas Analysis

D-dimer

Biomarkers

Electrocardiogram

Chest X Ray

Ventilation/Perfusion Scan

Echocardiography

Compression Ultrasonography

CT

MRI

Treatment

Treatment approach

Medical Therapy

IVC Filter

Pulmonary Embolectomy

Pulmonary Thromboendarterectomy

Discharge Care and Long Term Treatment

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Follow-Up

Support group

Special Scenario

Pregnancy

Cancer

Trials

Landmark Trials

Case Studies

Case #1

Pulmonary embolism differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary embolism differential diagnosis

CDC on Pulmonary embolism differential diagnosis

Pulmonary embolism differential diagnosis in the news

Blogs on Pulmonary embolism differential diagnosis

Directions to Hospitals Treating Pulmonary embolism differential diagnosis

Risk calculators and risk factors for Pulmonary embolism differential diagnosis

Editor(s)-In-Chief:C. Michael Gibson, M.S., M.D. [1], The APEX Trial Investigators; Associate Editor(s)-in-Chief:

Overview

Pulmonary embolism must be distinguished from other life-threatening causes of chest pain including acute myocardial infarction, aortic dissection, and pericardial tamponade, as well as a large list of non-life-threatening causes of chest discomfort and shortness of breath.

Disorders Pulmonary Embolism must be Differentiated From

References

  1. Restrepo CS, Artunduaga M, Carrillo JA, Rivera AL, Ojeda P, Martinez-Jimenez S; et al. (2009). "Silicone pulmonary embolism: report of 10 cases and review of the literature". J Comput Assist Tomogr. 33 (2): 233–7. doi:10.1097/RCT.0b013e31817ecb4e. PMID 19346851.

Template:WH Template:WS